trending Market Intelligence /marketintelligence/en/news-insights/trending/yn3m0f1xxdyhtd9glxx3gg2 content esgSubNav
In This List

Sanofi to start tender offers for Ablynx deal in April

Blog

Insight Weekly: PE firms shift strategies; bank earnings kick off; bankruptcies plummet

Blog

Insight Weekly: Stocks limp into 2023; GCC banks set for rebound; deep-sea mining faces pushback

Infographic

Infographic: The Big Picture 2023 Sustainability Outlook

Blog

The Big Picture for 2023: Assessing Investment Trends and the Impact of Investor Activism


Sanofi to start tender offers for Ablynx deal in April

Sanofi's tender offers to acquire all outstanding securities of Ablynx NV will start April 4.

The €3.9B acquisition secured antitrust clearances in U.S. and Germany earlier in March.

The French drugmaker will commence two concurrent tender offers — a tender offer under the laws of Belgium for all of the outstanding shares, warrants and convertible bonds of Ablynx, and a tender offer under the laws of the U.S. for all of the outstanding shares held by U.S. holders and American depositary shares held by holders, wherever located.

Sanofi will pay €45.00 per share or ADS, €18.66 to €41.79 per warrant, and €393,700.78 per convertible bond.

The offers will expire at 5 p.m. ET on May 4, subject to extension.

Sanofi said the tender offers are subject to customary conditions, including securities representing at least 75% of the outstanding shares of Ablynx at the end of the initial acceptance period of the tender offers.